Features | Partner Sites | Information | LinkXpress
Sign In
Schiller
GLOBETECH PUBLISHING
Ettin Group

Vascular Closure Device Preserves the Femoral Artery

By HospiMedica International staff writers
Posted on 28 Feb 2013
Image: The Vascade Vascular Closure System (VCS) (Photo courtesy of Cardiva Medical).
Image: The Vascade Vascular Closure System (VCS) (Photo courtesy of Cardiva Medical).
An innovative extravascular device facilitates entry site closure in patients undergoing percutaneous procedures through the femoral artery.

The Vascade Vascular Closure System (VCS) utilizes a unique delivery system based on a proprietary collapsible disc technology made of a biconvex low-profile nitinol, which provides temporary hemostasis during the procedure, eliminating the need for an intravascular component. Secure and rapid hemostasis is achieved by the deployment of a thrombogenic, resorbable collagen hemostatic coating patch, which accelerates coagulation at the arteriotomy site in the femoral artery by expanding approximately 13 times in volume, thus ensuring that the residual tissue tract is sufficiently filled and provides mechanical hemostasis.

The VCS is indicated for femoral arterial access site closure while reducing times to hemostasis and ambulation in patients who have undergone diagnostic or interventional endovascular procedures using a procedural sheath. The simple-to-use technique avoids the need for sheath exchange or added complexity, enabling deployment in as little as 30 seconds. The Vascade VCS is a product of Cardiva Medical (Sunnyvale, CA, USA), and has been approved by the US Food and Drug Administration (FDA).

“Vascade is a new generation of extravascular closure technology that offers significant advantages over conventional closure devices and manual compression,” said Frank Zidar, MD, of the Heart Hospital of Austin (TX, USA). “I am excited to be able to provide Vascade to my patients and to integrate it into my practice.”

The safety and effectiveness of Vascade VCS was evaluated in 420 patients across 21 clinical sites (up to 30 days post diagnostic or interventional procedures), that showed that the system is more effective than manual compression for mean time for hemostasis (TTH) and mean time to ambulation (TTA), and with fewer complications.

Related Links:

Cardiva Medical



ECR
Cincinnati Sub-Zero
ACEM

Channels

Critical Care

view channel
Image: The HAMILTON-T1 transport ventilator with neonatal option (Photo courtesy of Hamilton Medical).

Novel Transport Ventilator Now with Neonatal Option

A transport ventilator offers the same capabilities found in full featured neonatal intensive care unit (nICU) ventilators, but in a mobile format. The HAMILTON-T1 transport ventilator with neonatal... Read more

Women's Health

view channel

Aspirin Reduces Breast Cancer Recurrence in Overweight Women

The recurrence of hormone-related breast cancer was reduced by more than half in overweight and obese women who regularly used nonsteroidal anti-inflammatory drugs (NSAIDs), according to a new study. Researchers at the University of Texas (UT; Austin, USA) conducted a retrospective review of data from 440 women with... Read more

Business

view channel
Image: The Lift Labs tremor-cancelling spoon (Photo courtesy of Lift Labs).

Google Buys Hi-Tech Spoon Maker

Google (Mountain View, CA, USA) has bought Lift Labs (San Francisco, CA, USA), the maker of a tremor-cancelling spoon aimed at improving the lives of people suffering from Parkinson’s disease (PD) and... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.